The Luxembourg Parkinson’s study: Integrating the Lewy body composite risk score into a longitudinal study
Objective: To validate the LBCRS in a longitudinal national cohort study. The Lewy Body Composite Risk ScorePlease rate the following physical findings being present or…Parkinsonism risk factors in Salt Lake City, Utah
Objective: To assess the prevalence of risk factors for parkinsonism in Salt Lake City (SLC), Utah. Background: Recent data suggest that non-motor symptoms including constipation,…Exome sequencing in dementia with Lewy bodies
Objective: To perform a comprehensive analysis of genes previously implicated in dementia with Lewy bodies (DLB) by exome sequencing of a pathologically confirmed DLB cohort.…Alterations in 14-3-3 protein phosphorylation as a biomarker for neurodegeneration
Objective: To examine whether 14-3-3 phosphorylation is altered in Parkinson's disease and other neurodegenerative disorders. Background: 14-3-3 proteins are a highly conserved family of proteins…Spectral analysis of rapid eye movement (REM) sleep as a potential marker of neurodegenerative disease in REM sleep behavior disorder
Objective: To investigate whether spectral analysis at baseline in rapid eye movement (REM) sleep can differentiate patients with REM sleep behavior disorder (RBD) who will…Effects of zonisamide on dementia with Lewy bodies (DLB): A post-hoc analysis of phase 2 study for parkinsonism in DLB patients
Objective: To clarify the effects of zonisamide (ZNS) on the core symptoms of dementia with Lewy bodies (DLB), we performed a post-hoc analysis using data…Presenting symptoms and cognitive profile in Lewy body dementia: A series of cases
Objective: The study aim is to outline the Lewy body dementia (DLB) phenotypes as presenting symptoms and its correlation with cognitive profiles and clinical evolution…Heart rate variability to differentiate dementia with Lewy bodies from Alzheimer’s disease in patients with mild cognitive impairment
Objective: We aimed to determine whether heart rate variability (HRV) can aid in the differentiation of DLB from AD at the MCI stage. Background: Mild…MMSE and MoCA feasibility in Parkinson’s disease and dementia with Lewy bodies: A multicenter 1-year follow-up study
Objective: The aims of this study were to investigate which scale is best suited to assess cognition and more sensitive to cognitive decline over time…Modeling dementia with Lewy bodies using patient-derived neurons
Objective: To model Dementia with Lewy bodies (DLB) using neurons derived from patients clinically diagnosed with the disease. Background: A major challenge in neurodegenerative disease…
Abstracts from the International Congress of Parkinson’s and Movement Disorders.